| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc. (HALO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. HALO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 767.8K | $50.05M | - | |
| CFO | 29.5K | $1.92M | - | |
| VP | 29.5K | $1.92M | - | |
| COO | 13.0K | $850.5K | - | |
| Dir | 6.0K | $393.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Torley Helen61 | President And CEO | Sale+OE | 10,000 | $63.50 | $634,981.60 | -0.6% | - | - | |
| Jan 5, 2026 | Connaughton Bernadette49 | Director | Sell | 2,000 | $70.25 | $140,500.00 | -4.7% | -11.4% | - | |
| Dec 1, 2025 | Connaughton Bernadette49 | Director | Sell | 829 | $71.60 | $59,356.40 | -1.9% | +2.6% | - | |
| Dec 1, 2025 | Torley Helen61 | President And CEO | Sale+OE | 16,569 | $68.92 | $1,141,924.75 | -0.6% | +2.6% | - | |
| Nov 12, 2025 | Torley Helen61 | President And CEO | Sale+OE | 60,000 | $69.47 | $4,167,929.57 | -1.0% | +13.6% | - | |
| Nov 10, 2025 | Connaughton Bernadette49 | Director | Sell | 2,000 | $68.48 | $136,960.00 | -4.4% | +18.3% | - | |
| Nov 1, 2025 | Caudill Cortney | SVP, Chief Operating Officer | Sale+OE | 4,263 | $65.19 | $277,904.97 | -25.1% | +10.0% | - | |
| Oct 3, 2025 | Torley Helen61 | President And CEO | Sale+OE | 60,000 | $71.86 | $4,311,745.12 | -0.7% | +1.9% | - | |
| Oct 1, 2025 | Connaughton Bernadette49 | Director | Sell | 2,000 | $75.24 | $150,481.00 | -2.2% | -9.7% | - | |
| Sep 22, 2025 | Labrosse Nicole60 | SVP, Chief Financial Officer | Sell | 2,227 | $77.95 | $173,584.49 | -4.8% | -12.9% | - |